These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20558500

  • 1. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
    Laule C, Vavasour IM, Zhao Y, Traboulsee AL, Oger J, Vavasour JD, Mackay AL, Li DK.
    Mult Scler; 2010 Jun; 16(6):670-7. PubMed ID: 20558500
    [Abstract] [Full Text] [Related]

  • 2. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 3. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S, Seddigh A, Combes A, Russell-Schulz B, Tam R, Yogendrakumar V, Deoni S, Sibtain NA, Traboulsee A, Williams SC, Barker GJ, Brex PA.
    Neuroimage Clin; 2015 Aug; 9():574-80. PubMed ID: 26594633
    [Abstract] [Full Text] [Related]

  • 4. Multislice brain myelin water fractions at 3T in multiple sclerosis.
    Oh J, Han ET, Lee MC, Nelson SJ, Pelletier D.
    J Neuroimaging; 2007 Apr; 17(2):156-63. PubMed ID: 17441837
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach.
    Vaithianathar L, Tench CR, Morgan PS, Constantinescu CS.
    J Neurol; 2003 Mar; 250(3):307-15. PubMed ID: 12638021
    [Abstract] [Full Text] [Related]

  • 7. Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI.
    Agosta F, Benedetti B, Rocca MA, Valsasina P, Rovaris M, Comi G, Filippi M.
    Neurology; 2005 Feb 22; 64(4):631-5. PubMed ID: 15728283
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP, Rovaris M, Comi G, Filippi M.
    Neurology; 2009 Nov 10; 73(19):1538-42. PubMed ID: 19794123
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
    Khaleeli Z, Ciccarelli O, Mizskiel K, Altmann D, Miller DH, Thompson AJ.
    Mult Scler; 2010 Mar 10; 16(3):317-24. PubMed ID: 20203148
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D, Przuntek H, Sailer M, Bethke F, Koehler J, König N, Heesen C, Späth P, Andresen I.
    Mult Scler; 2007 Nov 10; 13(9):1107-17. PubMed ID: 17623736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlations between structural CNS damage and functional MRI changes in primary progressive MS.
    Filippi M, Rocca MA, Falini A, Caputo D, Ghezzi A, Colombo B, Scotti G, Comi G.
    Neuroimage; 2002 Mar 10; 15(3):537-46. PubMed ID: 11848696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.